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Background-—This study examined the association between ideal cardiovascular health (CVH) and the retinal microvasculature in
midadulthood.
Methods and Results-—The Cardiovascular Risk in Young Finns Study included children from 5 Finnish University cities, who were
chosen randomly from the national population register. Participants ranged from 12 to 18 years in childhood (1986) and from 37
to 43 years in midadulthood (2011). Ideal CVH was deﬁned according to the American Heart Association criteria. Retinal
microvascular measures included diameters, lengths, length:diameter ratio, and tortuosity. From childhood to adulthood, fasting
plasma glucose and blood pressure were signiﬁcantly higher in those with impaired fasting glucose or diabetes mellitus. Childhood
ideal CVH was negatively associated with adult arteriolar tortuosity (b=0.008; 95% conﬁdence interval [CI], 0.01 to 0.003;
P=0.001). Improved ideal CVH from childhood to adulthood was positively associated with adult arteriolar diameter (b=0.122; 95%
CI, 0.01–0.24; P=0.033) and negatively associated with adult length:diameter ratio (b=0.666; 95% CI, 1.25 to 0.08;
P=0.026). When stratiﬁed by glucose metabolism, among those with diabetes mellitus and impaired fasting glucose, there was a
negative association between childhood ideal CVH and adult venular diameter (diabetes mellitus: b=2.75; 95% CI, 5.46 to
0.04; P=0.047; impaired fasting glucose: b=2.13; 95% CI, 4.18 to 0.08; P=0.042).
Conclusions-—This study is the ﬁrst to comprehensively examine the impact of CVH from childhood to midadulthood on
quantitative measures of the retinal microvasculature. Ideal CVH in childhood and improvement in CVH from childhood to
adulthood appears to have a protective effect on the retinal microvasculature in those with, without, and at risk of diabetes
mellitus. ( J Am Heart Assoc. 2018;7:e009487. DOI: 10.1161/JAHA.118.009487)
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C ardiovascular disease (CVD) is the most common causeof death in the general population and in people with
type 2 diabetes mellitus.1 Clinical manifestations arising from
CVD usually occur late in the course of diabetes mellitus,
whereas subclinical abnormalities in the micro- and macrovas-
culature occur early.2 Newly emerging data highlight that the
microcirculation plays an important role in both the etiology
and pathology of CVD.3 In particular, the assessment of
retinal microvasculature characteristics, captured using reti-
nal imaging techniques, are associated with early stages of
subclinical CVD4 and are predictive of clinical CVD events in
both the general population and in people with type 2
From the School of Food Science and Nutrition (M.D.C.), and Multidisciplinary Cardiovascular Research Centre (M.D.C.), University of Leeds, United Kingdom; Research
Centre of Applied and Preventive Cardiovascular Medicine (T.L.T., K.P., M.J., O.T.R.), and Paavo Nurmi Centre, Sports & Exercise Medicine Unit, Department of Health
and Physical Activity (T.L.T., K.P.), University of Turku, Finland; Institute of Cardiovascular Science, University College London, United Kingdom (A.H.); Department of
Clinical Physiology, Tampere University Hospital and the Faculty of Medicine and Life Sciences (M.K.), Department of Clinical Chemistry, Fimlab Laboratories Faculty of
Medicine and Life Sciences (T.L.), and Department of Paediatrics, Tampere University Hospital (N.H.-K.), University of Tampere, Finland; Singapore National Eye Centre,
Singapore & Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, National University of Singapore (T.Y.W.); Department of Clinical
Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland (O.T.R.); School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, United
Kingdom (R.J.T.); Population Health Research Institute, St George’s University of London, United Kingdom (R.J.T.).
An accompanying Table S1 is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.118.009487
Correspondence to: Robyn J. Tapp, PhD, Population Health Research Institute, St Georges University of London, United Kingdom. E-mail: r.j.tapp@sgul.ac.uk
Received April 18, 2018; accepted August 31, 2018.
ª 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons
Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for
commercial purposes.
DOI: 10.1161/JAHA.118.009487 Journal of the American Heart Association 1
ORIGINAL RESEARCH
D
ow
nloaded from
 http://ahajournals.org by on November 9, 2018
diabetes mellitus.5–7 As such, the retinal microvasculature
can be regarded as a unique noninvasive lifetime summative
evaluation of the microvascular consequences of exposure to
cardiovascular insults and a valuable prognostic tool in
predicting future CVD risk.5–7
Nevertheless, our understanding of the mechanisms
leading to changes in retinal microvascular architecture is
limited owing to a lack of longitudinal studies from childhood
to adulthood. In the treatment of type 2 diabetes mellitus,
intensive glucose management has been shown to reduce the
risk of microvascular complications, such as diabetic
retinopathy and nephropathy.8 However, such beneﬁts do
not seem to translate to macrovascular and cardiovascular
end points.9 Information that can help predict and stratify
people at high and low risk of complications is needed. An
individual’s cardiovascular risk proﬁle can be determined
using a variety of metrics, such as those adopted by the
American Heart Association (AHA),10 comprising body mass
index, diet status, physical activity status, smoking status,
blood pressure (BP), and fasting plasma glucose. Extensive
evidence has demonstrated that low-risk (ideal)
cardiovascular proﬁles are associated with large reductions
in cardiovascular morbidity and mortality.11 In addition, low-
risk cardiovascular proﬁles in childhood and improvement in
cardiovascular health (CVH) status in adulthood result in
improvement of subclinical CVD risk factors later in life,12,13
which translates to lower CVD morbidity and mortality.14
Cross-sectional studies illustrate that those exposed to CVD
risk factors early in life concomitantly present suboptimal
structural changes in the retinal microvasculature.15 How-
ever, little is known about the long-term impact of CVD risk
proﬁle in early life on the structure and function of the retinal
microvasculature in later life or about whether this is
inﬂuenced by changes to CVD risk proﬁle throughout
adulthood. As such, our ability to draw causal inferences
and to examine the clinical predictive value of retinal imaging
remains signiﬁcantly hampered.
The Cardiovascular Risk in Young Finns Study provides a
unique opportunity to investigate the inﬂuence of CVD risk
proﬁles during childhood and across the life course into
midadulthood on retinal microvasculature architecture and
precursors of CVD. In this study, we applied a life-course
approach that considers the contribution of CVH in both
childhood and adulthood to examine the association
between ideal CVH and the retinal microvasculature in
midadulthood.
Methods
The Cardiovascular Risk in Young Finns Study is an ongoing
multicenter longitudinal epidemiological study of CVD risk
factors in a Finnish cohort from childhood to adulthood.16 A
cross-sectional survey was ﬁrst performed in 1980 on 3596
children and adolescents aged 3 to 18 years residing across 5
Finnish University cities and their rural surroundings, with
individuals being randomly selected from the national popu-
lation register.16 Since 1980, several follow-up observations
have been conducted, the latest of which was performed in
2011, in which 2063 participants (aged 34–49 years) from
the original cohort attended. For the present study, 1986 was
chosen as baseline because it was the ﬁrst year in which
glucose values were measured. In total, 418 participants aged
12 to 18 years underwent analysis owing to complete data on
CVH metrics from 1986 through 2011 and retinal parameters
in 2011. Participants were stratiﬁed by glucose metabolism
status as normal (without diabetes mellitus); impaired fasting
glucose; or diabetes mellitus, as determined by fasting plasma
glucose levels.
For CVH, we adopted the metrics outlined by the AHA,10
comprising body mass index, diet status, physical activity
status, smoking status, BP, and fasting plasma glucose.
Childhood ideal CVH metrics were applied for all participants
at baseline (1986) and subsequent time points (2001, 2007,
Clinical Perspective
What Is New?
• This study is the ﬁrst to comprehensively examine the
impact of cardiovascular health (CVH) from childhood to
midadulthood on quantitative measures of the retinal
microvasculature.
• We show that a detrimental change to CVH between
childhood and midadulthood is associated with narrowing of
the retinal arterioles and venular dilation in individuals with
diabetes mellitus and impaired fasting glucose.
• CVH in childhood is negatively associated with adult
arteriolar tortuosity, and people who improve their CVH
between childhood and midadulthood have similar
microvascular architecture to those who have ideal CVH
status in both childhood and adulthood.
What Are the Clinical Implications?
• We provide new evidence in support of the assessment of
the retinal microvasculature for cardiovascular disease
prediction.
• We provide essential insight into the predictive value of CVH
assessment in early life and the impact of life-course
changes in CVH proﬁle on subsequent outcomes to the
microvasculature in midadulthood.
• These ﬁndings suggest that the pursuit of ideal CVH
throughout the life course is important to prevent unfavor-
able retinal microvasculature changes but also that children
with poor CVH status are not predetermined to maintain the
risk if CVH is improved later in life.
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and 2011) and were age and sex speciﬁc.10 Data were
captured through the completion of questionnaires and
biometric analysis.
Fasting glucose concentrations were analyzed enzymatically
and classiﬁed in children and adults as ideal if <5.6 mmol/L
(<100 mg/dL)10; impaired fasting glucose levels were deﬁned
as a fasting plasma glucose between 6.1 and 6.9 mmol/L; type
2 diabetes mellitus was deﬁned as a fasting glucose level
>6.9 mmol/L and/or HbA1c ≥48 mmol/mol (6.5%), reported
use of oral glucose lowering medication or insulin (but not
reported having type 1 diabetes mellitus), or being diagnosed
with type 2 diabetes mellitus by a physician. Serum cholesterol
was analyzed as described previously,10 with ideal total
cholesterol status deﬁned as <4.4 mmol/L (<170 mg/dL) in
children and <5.2 mmol/L (<200 mg/dL) in adulthood. BPwas
measured using a random-zero sphygmomanometer, with ideal
BP status deﬁned as systolic BP and diastolic BP <90th
percentile in childhood and systolic BP <120 mm Hg and
diastolic BP <80mm Hg in adulthood. Body mass index (weight
in kilograms divided by height in square meters)10,11 was
classiﬁed as ideal in childhood if <85th percentile and in
adulthood as <25. Ideal diet for children and adults was deﬁned
as having 2 to 3 ideal diet components (fruits and vegetables,
ﬁsh, soft drinks) in 1986, as described previously10,17; in the
2011, the follow-up ideal diet for children and adults was
deﬁned as having 4 to 5 of the ideal diet components of the AHA
ideal dietary goals (fruits and vegetables, ﬁsh, sodium, whole
grains, and sugar-sweetened beverages), as described
previously.17 Ideal smoking status was classiﬁed in childhood
as never having smoked a cigarette and in adulthood as being a
never or former smoker. Ideal physical activity was classiﬁed in
childhood as ≥7 hours of moderate or vigorous activity per
week17 and in adulthood as ≥1 hour per week of vigorous
physical activity, ≥2 to 3 hours per week of moderate physical
activity, or ≥2 to 3 hours per week of a combination of
moderate and vigorous physical activity.17
From these individual health factors, a corresponding ideal
CVH score was generated. The score was created by
assigning a value of 1 for each metric if the criterion for
ideal was met. If a health factor did not meet this criterion, a
value of 0 was assigned, providing a range of ideal CVH scores
from 0 to 7, with a higher score indicating a better CVH
proﬁle. Low CVH was deﬁned as ≤3 metrics and high CVH as
≥4 metrics present.17 From this, we formed 4 groups from the
current cohort: high CVH in both childhood and adulthood
(high/high CVH); low CVH in childhood but high CVH in
adulthood (low/high CVH); high CVH in childhood but low
CVH in adulthood (high/low CVH); low CVH in both childhood
and adulthood (low/low CVH).
In 2011, 45° digital retinal imaging was performed using a
Canon nonmydriatic retinal camera (Canon CR6-45NM) ﬁtted
with a Canon 10D digital SLR camera (resolution: 307292048
pixels). Imageswere centered on themacula of each eye.Within
the present study, 1 pixel corresponds to 5 lm, and the
estimated diameter of arterioles was 100 lm. A range of
vascular geometric parameters were captured using a semiau-
tomated grading system including arteriolar and venular
diameters, as described previously by our group7; length:diam-
eter ratio (L:D ratio) of arteriolar segments (as a means of
normalizing vessel diameter)7; and arteriolar tortuosity, as
estimated as the actual length of the vessel divided by the
straight-line distance between bifurcations 1.7 Photographer
accreditation was performed before the beginning of the study,
with images being read at a single reader center (Imperial
College London). Imaging quality control was conducted
periodically throughout the study with 1 observer blinded to
subject data including the performance of retinal grading and
feedback. The reproducibility of this technique was excellent
(intraclass correlation coefﬁcients for within-observer mea-
surements were >0.9), and the average absolute difference and
standard deviation between measurements of arteriolar diam-
eter was 0.00.4 pixels, consistent with previous reports.
The study was conducted in compliance with the Decla-
ration of Helsinki and was approved by local ethics commit-
tees, with all participants providing full written informed
consent. The data, analytic methods, and study materials will
not be made available to other researchers for purposes of
reproducing the results or replicating the procedure.
Statistical Analysis
The data analysis was performed with Stata 12.0 IC
(StataCorp) and presented as meanSD with statistical
signiﬁcance inferred at a 2-tailed P<0.05; 95% conﬁdence
intervals (CIs) and b coefﬁcients are presented where
relevant. Descriptive information for each variable was
derived and the distribution assessed to determine normality.
One-way ANOVAs were performed to assess conditional
differences between groups stratiﬁed for glucose metabolism
status at each respective time point (Table 1). A life-course
epidemiologic approach was used that simultaneously con-
sidered the contribution of ideal CVH in both childhood and
adulthood.18 To study the association of childhood ideal CVH
score and change in the score (score in 2011 minus score in
1986) with retinal microvasculature measures in adulthood
(2011), linear regression models adjusted for baseline scores,
changes in the scores, age at baselines, and sex were
performed (Table 2 and Figure) with further analysis stratiﬁed
for glucose metabolism status (Table 3).
Results
In total, 417 participants underwent retinal imaging and
provided complete ideal CVH data. The characteristics of the
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Table 1. Ideal CVH Scores Across the Life Course and Retinal Microvasculature Measures by Categories of Glucose Metabolism
Normal IFG DM P Value
Participants, n 386 20 11 . . .
Characteristics (1986)
Age (12–18 y) 153 162 162 0.209
Ideal CVH score 3.51.0 3.90.7 3.30.9 0.282
BMI, kg/m2 20.02.7 20.42.4 21.82.6 0.293
Ideal diet, % 25.7 35.0 18.2 0.544
Ideal physical activity, % 5.4 0.0 0.0 0.411
Ideal smoking status, % 24.1 20.0 27.3 0.886
Systolic BP, mm Hg 11512 11511 12116 0.025
Diastolic BP, mm Hg 649 6411 6711 0.443
Fasting glucose, mmol/L 4.60.5 4.80.5 4.90.7 <0.001
Cholesterol, mmol/L 4.91.0 4.81.0 4.51.0 0.691
Characteristics (2001)
Age (27–33 y) 303 312 312 0.209
Ideal CVH score 4.31.4 2.81.4 3.81.4 0.062
BMI, kg/m2 24.54.1 25.84.3 26.64.5 0.112
Ideal diet, % 25.8 29.4 33.3 0.834
Ideal physical activity, % 57.1 31.3 63.6 0.110
Ideal smoking status, % 71.8 58.8 45.5 0.091
Systolic BP, mm Hg 11513 12111 12718 0.026
Diastolic BP, mm Hg 7010 7210 7813 0.012
Fasting glucose, mmol/L 5.00.5 5.40.6 5.40.5 0.002
Cholesterol, mmol/L 5.11.0 5.10.9 5.21.3 0.623
Characteristics (2007)
Age (33–39 y) 363 372 372 0.209
Ideal CVH score 3.81.4 2.51.3 2.11.5 <0.001
BMI, kg/m2 25.34.4 28.34.9 29.84.5 <0.001
Ideal diet, % 6.2 6.7 0.0 0.792
Ideal physical activity, % 52.0 40.0 66.7 0.441
Ideal smoking status, % 78.5 86.7 66.7 0.511
Systolic BP, mm Hg 11913 12714 13115 0.068
Diastolic BP, mm Hg 7411 8314 8313 <0.001
Fasting glucose, mmol/L 5.20.5 5.90.4 6.42.3 <0.001
Cholesterol, mmol/L 5.01.0 5.10.9 5.21.0 0.905
Characteristics (2011)
Age (37–43 y) 403 412 412 0.209
Ideal CVH score 3.81.4 2.20.9 2.51.4 <0.001
BMI, kg/m2 25.84.5 29.45.5 29.35.3 0.036
Ideal diet, % 3.7 10.0 0.0 0.243
Ideal physical activity, % 57.3 45.0 54.6 0.554
Ideal smoking status, % 83.7 80.0 54.6 0.039
Systolic BP, mm Hg 11613 12617 12514 0.011
Continued
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participants are shown in Table 1. When categorizing by
glucose metabolism status, there was a signiﬁcant difference
in systolic BP and fasting plasma glucose in childhood
(Table 1). Differences in systolic BP and fasting plasma
glucose between groups remained statistically signiﬁcant
from childhood throughout adulthood, coupled with ideal CVH
status, from 2007 onward (Table 1).
Table 2 shows the childhood ideal CVH and change in CVH
between childhood and adulthood in predicting retinal
microvascular complications in adulthood. Adult arteriolar
diameter was positively associated with improved ideal CVH
from childhood to adulthood (b=0.122; 95% CI, 0.010–0.235;
P=0.033), whereas no association was evident between adult
arteriolar diameter and childhood ideal CVH after adjustment
for age and sex. There was a negative association between
improved ideal CVH from childhood to adulthood and adult
arteriolar L:D ratio (b=0.666; 95% CI, 1.254 to 0.078;
P=0.026), with no association evident for childhood ideal
CVH, after adjustment for confounding factors. Improved ideal
CVH from childhood to adulthood showed no association with
adult arteriolar tortuosity, but childhood ideal CVH was
negatively associated with adult arteriolar tortuosity
(b=0.008; 95% CI, 0.012 to 0.003; P=0.001). No
associations were evident between improved ideal CVH from
childhood to adulthood or childhood ideal CVH with venular
measures.
Table 3 shows the childhood ideal CVH and change in CVH
between childhood and adulthood in predicting retinal
microvascular complications in adulthood by categories of
glucose metabolism. Among those with diabetes mellitus,
there was a positive association between childhood ideal CVH
and arteriolar length (b=158.6; 95% CI, 51.5–265.7; P=0.011)
and L:D ratio (b=13.03; 95% CI, 4.96–21.09; P=0.008),
respectively, with no association evident for improved ideal
CVH from childhood to adulthood after adjusting for con-
founding factors (age and sex). In addition, in those with
diabetes mellitus and IFG, there was a negative association
between change in ideal CVH from childhood to adulthood in
adult venular diameter (IFG: b=2.13; 95% CI, 4.18 to
0.08; P=0.042; diabetes mellitus: b=2.76; 95% CI, 5.47
to 0.04; P=0.047). Table S1 shows the individual ideal CVH
factors in childhood and change in individual ideal CVH factors
between childhood and adulthood for retinal microvascular
architecture in adulthood (using standardized b coefﬁcients).
FiguresA througD show age- and sex-adjusted mean
indexes and 95% CI of retinal microvasculature health
according to ideal CVH status in childhood and adulthood
by arteriolar diameter, length, L:D ratio, and tortuosity,
respectively. For each of the aforementioned arteriolar
measures (length; diameter; L:D ratio, tortuosity), there was
an indication of poorer retinal microvascular health in those
with persistently low CVH status in childhood and adulthood
and better retinal microvascular health in those with persis-
tently high CVH status in childhood and adulthood (FigureD).
The models were additionally rerun replacing fasting plasma
glucose with HbA1c to assess the potential mediating impact
of a second diagnostic criteria of glucose metabolism status
on retinal microvasculature health. There were no signiﬁcant
changes in the association between arteriolar and venular
measures with HbA1c.
Discussion
This study is the ﬁrst to comprehensively examine the impact
of CVH from childhood to midadulthood on quantitative
measures of the retinal microvasculature. Using a longitudinal
Table 1. Continued
Normal IFG DM P Value
Diastolic BP, mm Hg 7410 8211 8013 0.017
Fasting glucose, mmol/L 5.20.5 6.30.4 7.10.4 <0.001
HbA1c, mmol/mol 35.72.6 38.43.3 52.618.3 <0.000
Cholesterol, mmol/L 5.20.9 5.70.9 5.21.3 0.466
Retinal microvasculature (2011)
Arteriolar L:D ratio 22.08.6 22.88.6 25.512.3 0.679
Arteriolar diameter (pixels) 17.91.6 18.32.3 17.52.3 0.005
Arteriolar tortuosity 0.040.001 0.050.008 0.050.011 0.274
Venular L:D ratio 14.94.0 15.14.1 15.14.9 0.417
Venular diameter (pixels) 20.32.6 20.33.0 21.02.6 <0.001
Venular tortuosity 0.0130.0004 0.0130.0029 0.0160.012 0.624
Measures observed in 2011. Data presented as meanSD except as noted. Ideal physical activity (normal) and ideal smoking status (nonsmoker) are presented as percentage and Pearson
chi-square. BMI indicates body mass index; BP, blood pressure; CVH, cardiovascular health; DM, diabetes mellitus; IFG, impaired fasting glucose; L:D, length:diameter.
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life-course approach, we showed that childhood CVH and
deterioration in CVH (from childhood to midadulthood) were
associated with adverse changes in retinal microvascular
architecture in midadulthood. Moreover, we showed that
improvement in ideal CVH from childhood to adulthood was
associated with a protective effect on the retinal micro-
vasculature.
In the present study, we showed that a detrimental change
to CVH status between childhood and mid-adulthood was
associated with narrowing of the retinal arterioles. Retinal
arteriolar narrowing is associated with chronically elevated
BP19 and is one of the earliest retinal markers of hyperten-
sion.20 This ﬁnding is supported consistently in
epidemiological studies and meta-analyses that link narrower
arteriolar diameter and hypertension.19,21 Indeed, our group
and others have previously demonstrated that chronically
elevated BP from childhood has a profound effect on the
retinal microvasculature in midadulthood.22,23 The association
of worsening CVH status from childhood to midadulthood with
increased L:D ratio supports the ﬁndings shown for arteriolar
diameters; L:D ratio is used to normalize vessel diameter such
that it is relatively independent of refraction-induced magni-
ﬁcation effects. In addition, retinal arteriolar narrowing has
been reported to be associated with an increased risk of
diabetes mellitus in middle-aged people without diabetes
mellitus.24 Our data regarding adult retinal microvasculature
characteristics are comparable to recently published norma-
tive data.25 In our study, however, groups were stratiﬁed
based on fasting plasma glucose to assess microvascular
alterations in line with conventional risk factors.26 Notably,
differences in fasting glucose were evident between groups in
childhood (1986).
Body mass index as a component of ideal CVH status was
higher in those with diabetes mellitus and IFG from childhood
throughout adulthood. Those with diabetes mellitus and IFG
showed a negative association between changes in ideal CVH
from childhood to adulthood in adult venular diameter.
Venular dilation is commonly identiﬁed in obesity and in
individuals presenting with abnormal glucose metabolism
including diabetes mellitus27 and is associated with increased
risk of stroke mortality in type 2 diabetes mellitus.28 Whereas
the exact mechanisms providing linkage between obesity and
diabetes mellitus and venular dilation remain to be fully
established, both obesity and diabetes mellitus represent a
state of chronic inﬂammation, oxidative stress, and vascular
dysfunction29 that inﬂuences immunological, metabolic, and
cardiovascular function and that are associated with venular
dilation of the retina. Consequently, it is plausible that
disturbances to retinal venular endothelial function could
contribute to the association between change in ideal CVH
from childhood to adulthood and adult venular diameter in
those with diabetes mellitus and IFG.30
Our second key ﬁnding, that childhood ideal CVH is
negatively associated with adult arteriolar tortuosity, may be
clinically signiﬁcant. Patients presenting with ischemic stroke
are known to have a sparser and more tortuous retinal
microvascular network,31 and the Child Heart and Health
Study in England32 has shown an association between
arteriolar tortuosity and CVD risk factors (increased triglyc-
eride, total cholesterol, and low-density lipoprotein [LDL]
cholesterol, systolic and diastolic BP) among children.32 The
ﬁnding that arteriolar tortuosity in midadulthood is associated
with ideal CVH in childhood suggests that childhood CVH
status may be important in determining how tortuous the
retinal vessels are in adulthood. Indeed, the notion that CVD
Table 2. Childhood Ideal CVH and Change in CVH Between
Childhood and Adulthood in Predicting Retinal Microvascular
Complications in Adulthood in the Cardiovascular Risk in
Young Finns Study
Regression
Coefﬁcient 95% CI P Value
Arteriolar measures
Diameter
Childhood CVH 0.031 0.157 to 0.220 0.747
Change CVH 0.122 0.010–0.235 0.033
Length
Childhood CVH 9.31 25.41 to 6.78 0.256
Change CVH 8.99 18.60 to 0.60 0.066
L:D ratio
Childhood CVH 0.577 1.577 to 0.409 0.251
Change CVH 0.666 1.254 to 0.078 0.026
Tortuosity
Childhood CVH 0.008 0.012 to 0.003 0.001
Change CVH 0.001 0.001 to 0.002 0.551
Diameter
Childhood CVH 0.050 0.36 to 0.26 0.751
Change CVH 0.004 0.19 to 0.18 0.970
Length
Childhood CVH 0.44 8.54 to 7.67 0.916
Change CVH 1.74 6.57 to 3.09 0.480
L:D ratio
Childhood CVH 0.002 0.48 to 0.47 0.994
Change CVH 0.127 0.41 to 0.08 0.377
Tortuosity
Childhood CVH 0.0002 0.0013 to 0.0008 0.661
Change CVH 0.0002 0.0005 to 0.0008 0.596
Data adjusted for sex and age (1986). Regression coefﬁcients for a 1-U increase in
childhood ideal CVH score and ideal CVH change. CI indicates conﬁdence interval; CVH,
cardiovascular health; L:D, length:diameter.
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risk has primordial origins and that arterial architecture
abnormalities are present before adulthood33–35 is supported
by substantial evidence; it is also known that arterial
tortuosity persists following removal of the initiating
stimulus.36 The present study provides further evidence for
this and, as such, carries important implications for CVD
prevention. Whereas quantitative retinal vascular measures,
such as retinal vascular diameter, have been associated with
CVD in the general population in several large epidemiological
studies,27,37 these associations have not been extensively
studied in people with diabetes mellitus.
The retinal microvasculature assessments made in the
current study quantify the geometric branching network. Such
retinal vasculature measures reﬂect the optimal state of blood
distribution in the microvasculature.6,38 The microvasculature,
which has a speciﬁc role in regulating BP and offering nutrient
delivery, is sensitive to hyperglycemia-induced damage. There
is a linear relationship between glycosylated hemoglobin levels
and the development of microvascular complications39 such
that the criteria (eg, fasting glucose levels) used to deﬁne the
presence of diabetes mellitus are largely derived from the
occurrence of microvascular complications. Hyperglycemia is
associated with glycation end products, inﬂammation, and
oxidative stress, which in retina, has been shown to induce
abnormalities in the structure and function of the microvascu-
lature. Diabetes mellitus is known to be associated with
increased shear stress and microvascular endothelial dysfunc-
tion through hyperglycemic-related pathways.40 In addition to
such pathways, other mechanisms such as dyslipidemia and
inﬂammation enhance the development of microvascular
disease.41 Because microvasculature alterations may result in
a reduced ability of insulin tomediate glucose uptake in skeletal
muscles, microvascular disease has been hypothesized to
contribute to the development of diabetes mellitus.24
To date, the strength of associations between retinal
vascular changes and disease prediction has been relatively
modest. Although classical CVD risk factors (elevated serum
cholesterol level and BP) are used clinically to assess a
Figure. Age- and sex-adjusted mean (SE) indexes of retinal microvasculature health according to ideal cardiovascular health status in
childhood and adulthood in the Cardiovascular Risk in Young Finns Study. A, Arterial length. B, Arterial diameter. C, length:diameter (L:D) ratio.
D, Arterial tortuosity symmetry. HH indicates high ideal cardiovascular health (CVH) score (≥4 metrics) in both childhood and adulthood (n=117);
HL, high ideal CVH score in childhood but low ideal CVH score in adulthood (n=85); LH, low ideal CVH score (≤3 metrics) in childhood but high
ideal CVH score in adulthood (n=106); LL, low ideal CVH score in both childhood and adulthood (n=96).
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person’s risk of CVD, these risk factors do not fully explain the
higher risk of CVD events in those with diabetes mellitus.
Moreover, our study shows that people who improve their
CVH status by some means between childhood and midadult-
hood have microvascular architecture (arteriolar length,
diameter, and L:D ratio; Figure) similar to those who have
ideal CVH status in both childhood and adulthood. It is known
that disordered structure of the retinal microvasculature is
associated with hypertension,22 diabetes mellitus,30 and
retinopathy.28 Both narrowing of retinal arteriolar vessels
and widening of venules have been demonstrated to predict
subsequent ischemic heart disease and stroke.7,8 Arteriolar
narrowing in particular predicts development of
hypertension,27 and studies suggest that venular dilatation,
possibly due to localized ischemia, may predict the presence
or risk of impaired glucose tolerance and diabetes mellitus.6
As such, these ﬁndings suggest that the pursuit of ideal CVH
throughout the life course is important to prevent unfavorable
retinal microvasculature changes but also that those children
with poor CVH status are not predetermined to maintain the
risk if CVH is improved later in life.
The strengths of this study include its prospective design
and large sample size, the ascertainment of quantitative
retinal microvasculature status, complete data for ideal CVH
status from childhood to midadulthood, and the population-
representative nature of the cohort at the time of initial
Table 3. Childhood Ideal CVH and Change in CVH Between Childhood and Adulthood in Predicting Retinal Microvascular
Complications in Adulthood in the Cardiovascular Risk in Young Finns Study by Categories of Glucose Metabolism.
Normal IFG DM
Regression
Coefﬁcient 95% CI P Value
Regression
Coefﬁcient 95% CI P Value
Regression
Coefﬁcient 95% CI P Value
Arteriolar measures
Diameter
Childhood CVH 0.05 0.14 to 0.23 0.629 1.44 4.34 to 1.46 0.306 1.08 3.58 to 1.42 0.332
Change CVH 0.14 0.02–0.25 0.020 0.57 0.90 to 2.07 0.411 0.31 2.03 to 1.41 0.677
Length
Childhood CVH 10.7 27.3 to 5.9 0.206 50.5 124.9 to 226.0 0.549 158.6 51.5–265.7 0.011
Change CVH 9.6 19.9 to 0.6 0.066 31.7 58.1 to 121.6 0.463 26.6 100.4 to 47.2 0.412
L:D ratio
Childhood CVH 0.68 1.68 to 0.32 0.182 4.51 7.02 to 16.05 0.418 13.03 4.96–21.10 0.008
Change CVH 0.71 1.33 to 0.09 0.025 1.08 4.82 to 6.99 0.702 1.08 6.64 to 4.49 0.652
Tortuosity
Childhood CVH 0.01 0.01 to 0.00 0.001 0.01 0.06 to 0.07 0.859 0.01 0.08 to 0.05 0.623
Change CVH 0.00 0.00 to 0.00 0.867 0.00 0.03 to 0.04 0.907 0.02 0.03 to 0.06 0.395
Venular measures
Diameter
Childhood CVH 0.03 0.34 to 0.28 0.836 3.21 7.20 to 0.89 0.108 1.25 2.29 to 5.19 0.465
Change CVH 0.33 0.16 to 0.23 0.735 2.13 4.18 to 0.08 0.042 2.76 5.47 to 0.04 0.047
Length
Childhood CVH 0.37 8.7 to 8.0 0.931 30.0 94.0 to 36.0 0.357 31.6 83.4 to 76.5 0.527
Change CVH 1.8 1.8 to 2.6 0.496 12.6 45.9 to 20.6 0.430 2.8 82.0 to 76.5 0.935
L:D ratio
Childhood CVH 0.03 0.51 to 0.46 0.918 0.99 4.44 to 6.41 0.703 1.53 4.63 to 7.69 0.566
Change CVH 0.15 0.45 to 0.14 0.310 0.82 1.95 to 3.60 0.538 1.70 2.54 to 5.50 0.364
Tortuosity
Childhood CVH 0.00 0.00 to 0.00 0.867 0.00 0.01 to 0.01 0.674 0.00 0.02 to 0.01 0.583
Change CVH 0.00 0.00 to 0.00 0.449 0.00 0.00 to 0.01 0.375 0.00 0.01 to 0.01 0.922
Data adjusted for sex and age (1986). Regression coefﬁcients for a 1-U increase in childhood ideal CVH score and ideal CVH change. CI indicates conﬁdence interval; CVH, cardiovascular
health; DM, diabetes mellitus; IFG, impaired fasting glucose; L:D, length:diameter.
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recruitment in 1980. Over time, the study population lost
participants to follow-up, which may affect estimates; how-
ever, it is important to consider that the current study
assessed associations between risk factors and retinal
microvasculature outcomes, and it is unlikely that they will
have altered because of loss at follow-up unless associations
differed in those lost to follow-up. The study had a limited
number of participants with IFG and diabetes mellitus; further
follow-up in a cohort with a larger number of participants with
IFG and diabetes mellitus is warranted.
In conclusion, we provided new evidence in support of the
assessment of the retinal microvasculature for CVD prediction
and essential insight into the predictive value of CVH
assessment in early life and the impact of life-course changes
in CVH proﬁle on subsequent outcomes to the microvascu-
lature in midadulthood.
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Table S1. Childhood Ideal Cardiovascular Health factors and Change in Cardiovascular Health between 
Childhood and Adulthood in predicting Retinal Microvascular Complications in Adulthood in the YSF.	
Regression coefficient P Value 
Arteriolar Diameter 
Fasting glucose (mmol/l)      Childhood CVH 0.01 0.786 
     Change CVH -0.03 0.560 
Cholesterol      Childhood CVH -0.08 0.171 
     Change CVH 0.04 0.564 
Blood pressure (mm/Hg)      Childhood CVH 0.22 <0.001 
     Change CVH 0.29 <0.001 
Ideal Diet      Childhood CVH -0.13 0.291 
     Change CVH -0.12 0.333 
Ideal Smoking Status      Childhood CVH -0.06 0.380 
     Change CVH -0.10 0.172 
Ideal Physical Activity      Childhood CVH 0.00 0.941 
     Change CVH -0.02 0.697 
Arteriolar L-D Ratio 
Fasting glucose (mmol/l)      Childhood CVH -0.05 0.354 
     Change CVH 0.03 0.624 
Cholesterol      Childhood CVH -0.06 0.321 
     Change CVH -0.07 0.248 
Blood pressure (mm/Hg)      Childhood CVH -0.21 =0.001 
     Change CVH -0.21 =0.001 
Ideal Diet      Childhood CVH 0.08 0.523 
     Change CVH 0.05 0.686 
Ideal Smoking Status      Childhood CVH 0.12 0.106 
     Change CVH 0.09 0.261 
Ideal Physical Activity      Childhood CVH -0.03 0.612 
     Change CVH -0.03 0.618 
Arteriolar Tortuosity Symmetry 
Fasting glucose (mmol/l)      Childhood CVH 0.01 0.843 
     Change CVH -0.08 0.132 
Cholesterol      Childhood CVH -0.09 0.137 
     Change CVH 0.07 0.274 
Blood pressure (mm/Hg)      Childhood CVH -0.22 <0.001 
     Change CVH 0.12 0.046 
Ideal Diet      Childhood CVH -0.12 0.347 
     Change CVH -0.06 0.650 
Ideal Smoking Status      Childhood CVH -0.15 0.037 
     Change CVH -0.18 0.019 
Ideal Physical Activity      Childhood CVH -0.02 0.760 
     Change CVH 0.14 0.013 
Venular Length 
Fasting glucose (mmol/l)      Childhood CVH 0.05 0.298 
     Change CVH 0.11 0.039 
Cholesterol      Childhood CVH -0.04 0.544 
     Change CVH -0.04 0.501 
Blood pressure (mm/Hg)      Childhood CVH -0.08 0.188 
     Change CVH -0.04 0.503 
Ideal Diet      Childhood CVH 0.04 0.737 
     Change CVH -0.03 0.834 
Ideal Smoking Status      Childhood CVH -0.05 0.512 
     Change CVH -0.02 0.823 
Ideal Physical Activity      Childhood CVH -0.02 0.727 
     Change CVH 0.03 0.603 
Data adjusted for sex and age (1986). β = Beta standardized coefficient. Regression coefficients for a 1 unit 
increase in childhood ideal CVH score and ideal CVH change. L:D ratio = length / diameter ratio 
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